BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2024 8:03:28 AM | Browse: 51 | Download: 223
 |
Received |
|
2024-06-19 05:00 |
 |
Peer-Review Started |
|
2024-06-19 05:00 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-07-05 02:14 |
 |
Revised |
|
2024-07-18 01:01 |
 |
Second Decision |
|
2024-07-24 02:36 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-07-24 08:17 |
 |
Articles in Press |
|
2024-07-24 08:17 |
 |
Publication Fee Transferred |
|
2024-09-02 06:30 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-09-09 03:37 |
 |
Publish the Manuscript Online |
|
2024-09-20 08:03 |
ISSN |
2220-3230 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Urology & Nephrology |
Manuscript Type |
Systematic Reviews |
Article Title |
Review of plasma exchange and rituximab for prevention of recurrent focal segmental glomerulosclerosis after a prior graft loss
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Sophie Gharaei, Hashim Abbas and Durga Anil Kanigicherla |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Durga Anil Kanigicherla, MD, Doctor, Doctor, Department of Renal Medicine, Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, United Kingdom. durga.kanigicherla@mft.nhs.uk |
Key Words |
Focal Segmental Glomerulosclerosis; Glomerular Disease; Plasma Exchange; Rituximab; Transplantation |
Core Tip |
Patients with prior graft losses due to post-transplant recurrence of focal segmental glomerulosclerosis (FSGS) are at particularly high risk of re-recurrence in subsequent transplants. With scarcity of transplants and limited options, prevention becomes vital. However, there has been a recommendation against the use of pre-emptive measures to prevent recurrence. Currently, there is too little evidence described in the literature to draw clear conclusions on the efficacy of preventative treatment. This lack of evidence for benefit does not necessarily equate to evidence of lack of benefit. Larger controlled studies are needed to investigate the effectiveness of pre-emptive measures. |
Publish Date |
2024-09-20 08:03 |
Citation |
<p>Gharaei S, Abbas H, Kanigicherla DA. Review of plasma exchange and rituximab for prevention of recurrent focal segmental glomerulosclerosis after a prior graft loss. <i>World J Transplant</i> 2024; 14(4): 98155</p> |
URL |
https://www.wjgnet.com/2220-3230/full/v14/i4/98155.htm |
DOI |
https://dx.doi.org/10.5500/wjt.v14.i4.98155 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345